Specifications include, but are not limited to: Qualified companies to bid on an automated nucleic acid platform to be maintained by the Molecular Genomics Unit and used for laboratory response network (LRN) clinical testing throughout the State of Kansas. The automated nucleic acid extraction platform must meet the following requirements: Validated by CDC as an instrument that may be used for LRN-B nucleic acid extraction protocols. Instrument protocol must allow for specimen lysis to be performed off-board. For example, the specimen is lysed within a biosafety cabinet and then taken to the instrument, which is located outside of the biosafety cabinet. Service/Reagent support expected to continue beyond 5 years from purchase.